Education
About Us
Working with TipRanks
Follow Us
IRLAB Therapeutics AB Class A (DE:6IRA)
FRANKFURT:6IRA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 94.63M | kr 5.68M | kr 61.14M | kr 207.78M | kr 300.00K |
| Gross Profit | kr -92.42M | kr -122.73M | kr -111.23M | kr 168.69M | kr -1.70M |
| Operating Income | kr -75.11M | kr -180.76M | kr -113.11M | kr 52.58M | kr -91.46M |
| EBITDA | kr -68.07M | kr -173.32M | kr -109.13M | kr 55.79M | kr -89.46M |
| Net Income | kr -83.13M | kr -177.84M | kr -114.20M | kr 51.78M | kr -91.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 66.92M | kr 111.31M | kr 252.78M | kr 401.90M | kr 277.01M |
| Total Assets | kr 136.21M | kr 177.12M | kr 323.56M | kr 472.45M | kr 370.07M |
| Total Debt | kr 60.42M | kr 27.57M | kr 3.98M | kr 6.60M | kr 2.93M |
| Net Debt | kr -6.50M | kr -83.74M | kr -248.80M | kr -395.30M | kr -274.08M |
| Total Liabilities | kr 103.58M | kr 61.36M | kr 32.72M | kr 72.97M | kr 22.19M |
| Stockholders' Equity | kr 32.63M | kr 115.76M | kr 290.83M | kr 399.48M | kr 347.88M |
| Cash Flow | |||||
| Free Cash Flow | kr -65.79M | kr -165.14M | kr -145.99M | kr 127.93M | kr -89.61M |
| Operating Cash Flow | kr -65.59M | kr -164.85M | kr -142.61M | kr 128.64M | kr -89.21M |
| Investing Cash Flow | kr -199.00K | kr -293.00K | kr -3.38M | kr -708.00K | kr -394.00K |
| Financing Cash Flow | kr 21.40M | kr 23.68M | kr -3.13M | kr -3.04M | kr 256.09M |